The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery
Clinical trial NCT04277663 · TERMINATED
Trial details
- NCT number
- NCT04277663
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-17
- Primary completion
- 2023-02-28
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.